GEODE CAPITAL MANAGEMENT, LLC

Position in AEON — AEON Biopharma, Inc.

CIK 1214717 BOSTON, MA

Position in AEON

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$68,528

-$17,227 QoQ

Shares Held

95,311

+9.5% QoQ

Ownership

0.191%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 22 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. AEON ranks #462 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$68,528	95,311	+9.5%	Shares	Defined	2026-08-12
2026-03-31	$85,755	87,062	+44.8%	Shares	Defined	2026-05-15
2025-12-31	$66,146	60,134	+27.7%	Shares	Defined	2026-02-09
2025-09-30	$38,081	47,073	+127.5%	Shares	Defined	2025-11-12
2025-06-30	$15,727	20,695	-91.8%	Shares	Defined	2025-08-08
2024-12-31	$135,957	251,775	+3.5%	Shares	Defined	2025-02-12
2024-09-30	$255,326	243,168	+30.1%	Shares	Defined	2024-11-12
2024-06-30	$196,200	186,858	+4.0%	Shares	Defined	2024-08-09
2024-03-31	$2,083,302	179,595	+4.3%	Shares	Defined	2024-05-13
2023-12-31	$1,240,171	172,246	+0.5%	Shares	Defined	2024-02-13
2023-09-30	$959,537	171,346	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.